跳至主要内容
临床试验/IRCT20200115046136N1
IRCT20200115046136N1已完成3 期

Evaluating the protective effect of oral ginseng in patients with thyroid cancer following administration of high levels of radioactive iodine by measuring micronuclei and some biochemical factors

Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Patients between the ages of 30 and 60 who had thyroid cancer and underwent thyroid surgery.
  • Patients who first receive radioactive iodine.

排除标准

  • People who have undergone radiotherapy or chemotherapy in the last year.
  • People with certain genetic diseases.
  • People taking medications for heart and kidney failure, and those who take Warfarin anticoagulants definitively.
  • People who smoke.
  • People who are radiant
  • People who have taken ginseng in the last month.

研究者

相似试验

Radioprotective effect of ginseng in thyroid cancer... | 临床试验